{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:37:40Z","timestamp":1790257060548,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T00:00:00Z","timestamp":1324598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s12031-011-9696-y","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T07:32:29Z","timestamp":1324539149000},"page":"139-143","source":"Crossref","is-referenced-by-count":38,"title":["Clinical and Pathological Characteristics of LRRK2 G2019S Patients with PD"],"prefix":"10.1007","volume":"47","author":[{"given":"Markos","family":"Poulopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etty","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul G.","family":"Vonsattel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Fahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucien J.","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Moskowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Honig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine N.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Marder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy N.","family":"Alcalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,23]]},"reference":[{"issue":"10","key":"9696_CR1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.parkreldis.2010.09.003","volume":"16","author":"S Belarbi","year":"2010","unstructured":"Belarbi S, Hecham N et al (2010) LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort. Parkinsonism Relat Disord 16(10):676\u2013679","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"9696_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K et al (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"5","key":"9696_CR3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00401-006-0178-1","volume":"113","author":"JC Dachsel","year":"2007","unstructured":"Dachsel JC, Ross OA et al (2007) Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions. Acta Neuropathol 113(5):601\u2013606","journal-title":"Acta Neuropathol"},{"key":"9696_CR4","first-page":"165","volume":"39","author":"SE Daniel","year":"1993","unstructured":"Daniel SE, Lees AJ (1993) Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39:165\u2013172","journal-title":"J Neural Transm Suppl"},{"issue":"6","key":"9696_CR5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jnnp.2006.107904","volume":"78","author":"C Gaig","year":"2007","unstructured":"Gaig C, Marti MJ et al (2007) G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. J Neurol Neurosurg Psychiatr 78(6):626\u2013628","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"1\u20132","key":"9696_CR6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2008.02.010","volume":"270","author":"C Gaig","year":"2008","unstructured":"Gaig C, Ezquerra M et al (2008) Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration. J Neurol Sci 270(1\u20132):94\u201398","journal-title":"J Neurol Sci"},{"issue":"2","key":"9696_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.20791","volume":"59","author":"BI Giasson","year":"2006","unstructured":"Giasson BI, Covy JP et al (2006) Biochemical and pathological characterization of Lrrk2. Ann Neurol 59(2):315\u2013322","journal-title":"Ann Neurol"},{"issue":"9457","key":"9696_CR8","first-page":"415","volume":"365","author":"WP Gilks","year":"2005","unstructured":"Gilks WP, Abou-Sleiman PM et al (2005) A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365(9457):415\u2013416","journal-title":"Lancet"},{"issue":"2","key":"9696_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-010-0669-y","volume":"120","author":"A Gomez","year":"2010","unstructured":"Gomez A, Ferrer I (2010) Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment. Acta Neuropathol 120(2):155\u2013167","journal-title":"Acta Neuropathol"},{"issue":"7","key":"9696_CR10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M et al (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7(7):583\u2013590","journal-title":"Lancet Neurol"},{"issue":"6","key":"9696_CR11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG et al (2008) The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20\u00a0years. Mov Disord 23(6):837\u2013844","journal-title":"Mov Disord"},{"issue":"3","key":"9696_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 55(3):181\u2013184","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"4","key":"9696_CR13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc055540","volume":"354","author":"S Lesage","year":"2006","unstructured":"Lesage S, Durr A et al (2006) LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 354(4):422\u2013423","journal-title":"N Engl J Med"},{"issue":"1","key":"9696_CR14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.410350113","volume":"35","author":"CF Lippa","year":"1994","unstructured":"Lippa CF, Smith TW et al (1994) Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 35(1):81\u201388","journal-title":"Ann Neurol"},{"issue":"6","key":"9696_CR15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archneurol.2010.95","volume":"67","author":"KS Marder","year":"2010","unstructured":"Marder KS, Tang MX et al (2010) Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol 67(6):731\u2013738","journal-title":"Arch Neurol"},{"issue":"4","key":"9696_CR16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","volume":"354","author":"LJ Ozelius","year":"2006","unstructured":"Ozelius LJ, Senthil G et al (2006) LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 354(4):424\u2013425","journal-title":"N Engl J Med"},{"issue":"4","key":"9696_CR17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/mds.21343","volume":"22","author":"LJ Ozelius","year":"2007","unstructured":"Ozelius LJ, Foroud T et al (2007) G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Mov Disord 22(4):546\u2013549","journal-title":"Mov Disord"},{"issue":"8","key":"9696_CR18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000240220.33950.0c","volume":"67","author":"A Rajput","year":"2006","unstructured":"Rajput A, Dickson DW et al (2006) Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology 67(8):1506\u20131508","journal-title":"Neurology"},{"issue":"2","key":"9696_CR19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.20731","volume":"59","author":"OA Ross","year":"2006","unstructured":"Ross OA, Toft M et al (2006) Lrrk2 and Lewy body disease. Ann Neurol 59(2):388\u2013393","journal-title":"Ann Neurol"},{"issue":"13","key":"9696_CR20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1212\/01.wnl.0000326575.20829.45","volume":"71","author":"L Silveira-Moriyama","year":"2008","unstructured":"Silveira-Moriyama L, Guedes LC et al (2008) Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 71(13):1021\u20131026","journal-title":"Neurology"},{"issue":"12","key":"9696_CR21","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/ibd.21651","volume":"17","author":"J Umeno","year":"2011","unstructured":"Umeno J, Asano K et al (2011) Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 17(12):2407\u20132415","journal-title":"Inflamm Bowel Dis"},{"issue":"1\u20133","key":"9696_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000289232","volume":"7","author":"C Wider","year":"2010","unstructured":"Wider C, Dickson DW et al (2010) Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. Neurodegener Dis 7(1\u20133):175\u2013179","journal-title":"Neurodegener Dis"},{"issue":"4","key":"9696_CR23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44(4):601\u2013607","journal-title":"Neuron"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-011-9696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-011-9696-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-011-9696-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:19:35Z","timestamp":1559441975000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-011-9696-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,23]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["9696"],"URL":"https:\/\/doi.org\/10.1007\/s12031-011-9696-y","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,23]]}}}